Showing results (551-560 of 569) with videos related to

Sort By:
Pageof 57
Plos Computational Biology|December 17, 2009
The GAAS metagenomic tool and its estimations of viral and microbial average genome size in four major biomesFlorent E Angly, Dana Willner, Alejandra Prieto-Davó, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2019
Genomic and molecular characterization of preterm birthTheo A Knijnenburg, Joseph G Vockley, Nyasha Chambwe, et al.
The New England Journal of Medicine|March 18, 2017
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk PatientsPaul M Ridker, James Revkin, Pierre Amarenco, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II DiabetesPing Liu, Zhiyong Hu, Byron G DuBois, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2023
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised PatientsGhady Haidar, Jana L Jacobs, Kailey Hughes Kramer, et al.
BMC Veterinary Research|July 3, 2024
Mortality in sea lions is associated with the introduction of the H5N1 clade 2.3.4.4b virus in Brazil October 2023: whole genome sequencing and phylogenetic analysisAndreina de Carvalho Araujo, Andrew Yong Cho, Laura Morais Nascimento Silva, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: modifications of the arylpropylpiperidine side chainsChristopher L Lynch, Christopher A Willoughby, Jeffrey J Hale, et al.
Journal of Medicinal Chemistry|February 18, 2014
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonistDuane DeMong, Xing Dai, Joyce Hwa, et al.
Vaccine: X|February 6, 2024
Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United StatesJ Bradley Layton, Lauren Peetluk, Hui Lee Wong, et al.
BMC Pediatrics|April 26, 2024
Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort studyRachel P Ogilvie, J Bradley Layton, Patricia C Lloyd, et al.
Pageof 57